Harbor Capital Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $983K | Buy |
24,267
+3,499
| +17% | +$142K | 0.04% | 437 |
|
|
2025
Q1 | $1.07M | Sell |
20,768
-1,345
| -6% | -$69.1K | 0.05% | 421 |
|
|
2024
Q4 | $1.22M | Buy |
22,113
+4,008
| +22% | +$222K | 0.05% | 414 |
|
|
2024
Q3 | $595K | Buy |
18,105
+6,612
| +58% | +$217K | 0.03% | 545 |
|
|
2024
Q2 | $312K | Sell |
11,493
-127
| -1% | -$3.45K | 0.02% | 601 |
|
|
2024
Q1 | $422K | Buy |
+11,620
| New | +$422K | 0.06% | 441 |
|